AI boosts breast cancer detection by 10.4% in UK screening evaluation

The UK's first comprehensive evaluation of the use of Artificial Intelligence (AI) in breast cancer screening found that it can increase breast cancer detection by 10.4% and has the potential to reduce the workload of health care workers by more than 30% compared to the current clinical process. Published today in Nature Cancer, the evaluation was carried out by a team of scientists, clinicians and software developers from the University of Aberdeen, NHS Grampian, and Kheiron Medical Technologies, now part of DeepHealth Inc.